Cortical Processing of Proprioception Related to Pitching Performance in Baseball Players With Glenohumeral Internal Rotation Deficit

December 16, 2025 updated by: National Taiwan University Hospital
The current study aims to characterize the cortical activity and proprioceptive acuity in baseball players with glenohumeral internal rotation deficit (GIRD). Additionally, the correlations between cortical activity, proprioceptive acuity, and pitching performance will be examined. The evaluation of proprioception will be conducted using the active joint reposition sense of the shoulder. Simultaneously, the investigators will record cortical activity by electroencephalography (EEG). To represent pitching performance, the investigators will collect ball velocity and pitching accuracy. This will help the investigators understand the process of proprioception in the central nervous system, as well as factors associated with pitching performance in baseball players with GIRD.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

98

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taiwan
      • Taipei, Taiwan, Taiwan, 100
        • Institute of Physical Therapy, National Taiwan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

GIRD is defined as 20° less GH IR ROM in the dominant shoulder compared to the non-dominant shoulder. Players without GIRD will be recruited to match the characteristics and sports involvement data (age ±3 years, right-handed or left-handed, pitcher or fielder, practice time >10 hours/week or <10 hours/week, baseball experience >3 years or <3 years) of the GIRD players.

Description

Inclusion Criteria:

  • playing baseball for at least one year
  • still active in training or competition
  • frequency of training or games should be at least 3 hours per week

Exclusion Criteria:

  • current dominant upper extremities pain
  • a history of upper extremities surgical interventions or fractures or dislocation or degenerative joint disease
  • cervical radiculopathy within 6 months
  • lower extremities injury or surgery within the current 6 months
  • Visual analog scale (VAS) > 5 during movement in the experiment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
baseball players with GIRD
participants pitch fastball to the strike zone
baseball players without GIRD
participants pitch fastball to the strike zone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Active joint reposition test
Time Frame: baseline
Participants will mimic the pitching motion with reducing the influence from the lower limb by kneeling the knee and hip of the nondominant side 90° and their foot are flat on the ground. They will be blindfolded, with their non-throwing hand resting on the thigh. The reproducing arm-cocking and ball-release positions will be tested at random sequences for six trials, respectively. Results or feedback regarding the accuracy of individual trials will not be provided at any time. The acuity of active joint reposition will be calculated by 3-dimensional variable error scores for scapulothoracic (internal-external rotation, upward-downward rotation, posterior-anterior tilt) and glenohumeral (internal-external rotation, horizontal abduction-adduction, abduction-adduction) joint 55. Three-dimensional variable error scores (3DVE) reflect acuity (measured in degrees) in all planes of motion measured for individual joints.
baseline
Pitching performance
Time Frame: baseline

Pitching performance will be collected by radar gun (JUGS company, Tualatin, OR, USA) and digital camera (JVC GC-PX100B, Yokohama, Japan) for ball velocity and pitching location, respectively. Participants will pitch on a mound 18.44 m away from the home plate. The target will be aligned with the theoretical line extending from the right edge of the home plate at a height of approximately 30 cm above the ground.

After warming up at their own pace, each participant throws 30 game-like effort pitches in three 10-pitch sessions without specific instruction on focusing their attention. The fastest velocity of 10 pitches will be collected for analysis.

baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder range of motion
Time Frame: baseline

The tester grasps the subject's forearm in a supine position to measure the shoulder horizontal adduction/abduction. The humerus will be moved until the movement ceases (firm end-feel), indicating the end of shoulder tissue flexibility. The recorder places the digital inclinometer parallel to the humerus. Each measurement will be performed 3 times, and the average data will be analyzed.

GH internal/external (IR/ER) ranges will be measured accordingly following the method in a previous study. Participants lay down supine with 90° shoulder abduction and elbow flexion. Then GH IR/ER will be measured by the main assessor using a digital inclinometer by stabilizing the scapula by grasping the coracoid process and the spine of the scapula posteriorly, then moving the forearm to reach the end range. Each measurement will be performed 3 times, and the average data will be used for analysis.

baseline
Humeral retrotorsion
Time Frame: baseline
Humeral retrotorsion will be measured with the T3300 ultrasound system (BenQ, Taipei, Taiwan). Participants lay supine with 90° shoulder abduction and elbow flexion. The main assessor places the transducer on the participant's anterior shoulder for a short-axis view of the lesser and greater tubercles. The two-person technique is adopted. The first assessor adjusts the probe perpendicular to the floor and rotates the participant's humerus with a line connecting the greater and lesser tubercles parallel to the horizontal plane. Then, the second assessor places a digital inclinometer on the ulnar side of the forearm to record the rotation angle, which is defined as the humeral retroversion.23 The ICC3,k of intra-rater reliability is 0.995. Each measurement will be performed 3 times, and averaged data will be used for analysis.
baseline
Acromiohumeral distance
Time Frame: baseline
Acromiohumeral distance will be measured with the ultrasound transducer placed on the lateral aspect of the acromion in line with the longitudinal axis of the humerus to visualize the shortest distance between the humerus and the acromion.58 Three consecutive ultrasound images of the acromiohumeral distance are captured. The investigator captures 3 more consecutive ultrasound images at rest while the participant sit with the shoulder in the neutral position. The shortest distance will be measured with built-in calipers. The ICC3,k for intra-rater reliability is 0.963. Each measurement will be performed 3 times and averaged data will be used for analysis.
baseline
Rotator cuff thickness
Time Frame: baseline
The probe will be positioned on the bicipital grove horizontally to measure subscapularis tendon thickness in a short axis of view. The participant's forearm is placed with the elbow flexed to 90° in slight internal rotation, with the palm facing upward and medially. This position allows the bicipital groove to be brought to an anterior position, allowing clear visualization of the tendon within the grove. .
baseline
Posterior capsule thickness
Time Frame: baseline
For measurement of the posterior capsule thickness, the participants sit upright in a chair with both forearms resting on the thighs and upper arms by the participant's sides. The examiner positions a transducer on the posterior shoulder and visualizes the glenoid labrum, humeral head, rotator cuff, and posterior capsule. The posterior capsule is defined as the tissue immediately lateral to the tip of the labrum between the humeral head and rotator cuff. When the capsule is identified in the image, posterior capsule thickness will be measured with built-in calipers. The ICC3,k for intra-rater reliability is 0.951. Each measurement will be performed 3 times, and averaged data will be used for analysis.
baseline
Kerlan-Jobe Orthopaedic Clinic Shoulder and Elbow score (KJOC)
Time Frame: baseline
The KJOC is the most common questionnaire for overhead athletes, and it was conducted in several studies.66 Recently, the Major League Baseball (MLB) organization adopted this evaluation tool as the standard for recovering injuries in MLB players.67 The questionnaire is commonly used to assess shoulder function and performance. It is valid, reliable in its pilot form, and responsive to the tested population of adult overhead athletes.66 KJOC questionnaire ranges from 0 to 100, and the lower score represents a limited function.
baseline
Posterior capsule elasticity
Time Frame: baseline
To measure the posterior capsule elasticity, the participants sit upright in a chair with both forearms resting on the thighs and upper arms by the participant's sides. The examiner positions a transducer on the posterior shoulder and visualizes the glenoid labrum, humeral head, rotator cuff, and posterior capsule. The posterior capsule is defined as the tissue immediately lateral to the tip of the labrum between the humeral head and rotator cuff. When the capsule is identified in the image, posterior capsule elasticity will be recorded. Each measurement will be performed 3 times and averaged data will be used for analysis.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 20, 2024

Primary Completion (Actual)

May 30, 2025

Study Completion (Actual)

July 30, 2025

Study Registration Dates

First Submitted

August 21, 2024

First Submitted That Met QC Criteria

November 24, 2024

First Posted (Actual)

November 26, 2024

Study Record Updates

Last Update Posted (Actual)

December 17, 2025

Last Update Submitted That Met QC Criteria

December 16, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 202407026RINB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glenohumeral Internal Rotation Deficit

Clinical Trials on pitching motion

Subscribe